NCT00038558View on ClinicalTrials.gov

Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

February 29, 2004

Study Completion Date

March 31, 2005

Conditions
Hodgkin Disease
Interventions
DRUG

Filgrastim SD/01

DRUG

Adriamycin

DRUG

Bleomycin

DRUG

Vinblastine

DRUG

DTIC

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00038558 - Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy | Biotech Hunter | Biotech Hunter